Literature DB >> 8415393

Tertiary amines related to brompheniramine: preferred conformations for N-oxygenation by the hog liver flavin-containing monooxygenase.

J R Cashman1, J R Celestial, A Leach, J Newdoll, S B Park.   

Abstract

The metabolism of racemic, (D)- and (L)-brompheniramine, a widely used antihistamine, was studied with microsomes and with highly purified flavin-containing monooxygenase (FMO) from hog liver. In addition, a number of other similar tertiary amines were evaluated as substrates for FMO activity from hog liver and the kinetic constants obtained were compared with brompheniramine. Although some N-demethylation was observed, the major metabolite of brompheniramine and the other tertiary amines examined in hog liver microsomes was the metabolite containing an aliphatic nitrogen N-oxide. Brompheniramine was extensively N-oxygenated by the highly purified FMO from hog liver. N-Oxygenation of brompheniramine in both microsomes and with highly purified FMO from hog liver was enantioselective. The Km for N-oxygenation of (D)-brompheniramine was markedly lower than the Km for (L)-brompheniramine. (E)- and (Z)-zimeldine are less conformationally flexible model compounds of brompheniramine, and these compounds were also examined and were found to be stereoselectively N-oxygenated by the highly purified FMO from hog liver. The similarities and differences in Km and Vmax values were evaluated in terms of possible conformations of the substrates determined by SYBYL molecular mechanics calculations. Distance map data indicated that FMO preferentially accommodated selected conformations of tertiary amines. Thus, (D)-brompheniramine and (Z)-zimeldine presumably have the aliphatic tertiary amine nitrogen atom and aromatic ring center at a defined distance and geometry and were more efficiently N-oxygenated than their respective isomers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415393     DOI: 10.1023/a:1018947714030

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Analysis of amine metabolites by high-performance liquid chromatography on silica gel with a non-aqueous ionic eluent.

Authors:  J R Cashman; Z C Yang
Journal:  J Chromatogr       Date:  1990-11-16

2.  Metabolism of brompheniramine.

Authors:  R B Bruce; L B Turnbull; J H Newman; J E Pitts
Journal:  J Med Chem       Date:  1968-09       Impact factor: 7.446

3.  H1 antihistamines: perspective on the use of the conventional and new agents.

Authors:  M A Drouin
Journal:  Ann Allergy       Date:  1985-11

4.  Cloning, primary sequence, and chromosomal mapping of a human flavin-containing monooxygenase (FMO1).

Authors:  C Dolphin; E A Shephard; S Povey; C N Palmer; D M Ziegler; R Ayesh; R L Smith; I R Phillips
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

5.  The pharmacokinetics and antihistaminic effects of brompheniramine.

Authors:  F E Simons; E M Frith; K J Simons
Journal:  J Allergy Clin Immunol       Date:  1982-12       Impact factor: 10.793

6.  Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.

Authors:  S B Ross; A L Renyi
Journal:  Neuropharmacology       Date:  1977-01       Impact factor: 5.250

7.  Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.

Authors:  J R Cashman; D M Ziegler
Journal:  Mol Pharmacol       Date:  1986-02       Impact factor: 4.436

8.  Enantioselective S-oxygenation of 2-aryl-1,3-dithiolanes by rabbit lung enzyme preparations.

Authors:  J R Cashman; D E Williams
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

9.  The pharmacology of zimelidine: a 5-HT selective reuptake inhibitor.

Authors:  S O Ogren; S B Ross; H Hall; A C Holm; A L Renyi
Journal:  Acta Psychiatr Scand Suppl       Date:  1981

10.  Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites.

Authors:  J Lundström; T Högberg; T Gosztonyi; T de Paulis
Journal:  Arzneimittelforschung       Date:  1981
View more
  1 in total

Review 1.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.